BCL2 and hepatocellular carcinoma: In addition, the levels of Bax were increased in SAHA-treated A549 and Calu-6 cells whereas the levels of Bcl-2 were decreased in A549, Calu-6, HCC-33 and NCI-H69 cells (Figure 4C and Supplementary Figure 2C).